The effect of progestins on proliferation of breast cancer has been a contr
oversial area. We have consistently reported progestin stimulation of proli
feration in the progesterone receptor-rich human breast cancer cell line T4
7D. Other authors, under other conditions, have agreed that progestins stim
ulate, but for just one turn of the cell cycle. To our knowledge, this is t
he first in vitro report to show progestin stimulation of human breast canc
er cell growth for multiple, probably unlimited, cell cycles, while control
cells are dying. This is accompanied by progestin up-regulation of the ant
iapoptotic protein bcl-xL, no effect on the pro-apoptotic protein bar, and,
surprisingly, diminution of the antiapoptotic protein bcl-2. Thus, progest
ins both serve as survival factors and stimulate proliferation, implying a
possible similar role in breast cancer patients. The data support the notio
n that many patients may benefit more from combined antiprogestin-antiestro
gen therapy than from antiestrogen alone, and suggest bcl-x(L) as a possibl
e target for breast cancer therapy. (C) 2000 Academic Press.